Pictet Asset Management
HRMY icon

Pictet Asset Management’s Harmony Biosciences HRMY Stock Holding History

Pictet Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.97M Buy
196,898
+33,791
+21% +$1.07M 0.01% 754
2026
Q1 		$4.4M Sell
163,107
-44,286
-21% -$1.45M ﹤0.01% 797
2025
Q4 		$7.86M Sell
207,393
-9,868
-5% -$324K 0.01% 726
2025
Q3 		$6M Buy
217,261
+30,391
+16% +$1.05M 0.01% 771
2025
Q2 		$5.97M Buy
186,870
+35,377
+23% +$1.14M 0.01% 758
2025
Q1 		$5.03M Buy
+151,493
New +$5.43M 0.01% 800

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management's HRMY Position: Q2 2026 in Review

Pictet Asset Management increased its Harmony Biosciences (HRMY) stake by 21% in Q2 2026, buying an estimated $1.07M and bringing the position to 196,898 shares worth $6.97M. The position accounts for 0.01% of the portfolio, ranked #754.

Pictet Asset Management first reported a position in HRMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.86M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Pictet Asset Management held 196,898 shares of Harmony Biosciences worth $6.97M as of Q2 2026.
  • Pictet Asset Management bought 33,791 Harmony Biosciences shares in Q2 2026, an estimated $1.07M.
  • Harmony Biosciences made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #754 holding.
  • Pictet Asset Management first reported a position in Harmony Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Pictet Asset Management's Harmony Biosciences position peaked at $7.86M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.